Portland, OR -- (SBWIRE) -- 09/18/2017 -- Vero cell media contains vero cells extracted from kidney of African green monkey called as called Cercopithecus aethiops, which are most commonly used mammalian continuous cell lines in microbiological and molecular disciplines. These continuous cell lines are employed in biological studies, propagation, and analysis of intracellular bacteria & parasites. Moreover, vero cell media is also utilized to evaluate effects of various toxins and chemicals on mammalian cells.
Increase in incidences of chronic diseases, surge in regulatory approvals of cell culture-based vaccines, and growth in fundings for cell-based research drive the market. Moreover, technological advancements in cell culture product are expected to fuel the vero cell media market. However, high cost of research in cell biology and lack of research-based infrastructure impedes the growth of the vero cell media market. Increase in R&D activities for the advancement of healthcare is expected to offer new growth opportunities.
The global vero cell media market is segmented on the basis of type, application, and geography. By type, it is bifurcated into epithelial and internal. Based on application, the market is divided into scientific research and industrial production. By region, it is analyzed across North America, Europe, Asia Pacific, and LAMEA. These regions are further analyzed across the globe at country level to determine the market size and forecast for each segment and sub-segment.
Access Full Summary at: https://www.alliedmarketresearch.com/vero-cell-media-market
Comprehensive competitive analysis and profiles of major market players such as Biological Industries, Lonza, Sigma-Aldrich, Boster Bio, Serana Bio, Dickinson, Arcomed AG, Hospira Inc, Terumo Medical Corporation, and Mindray Medical International Limited are provided in this report.
Request Report Sample: https://www.alliedmarketresearch.com/request-toc-and-sample/3996
Vero Cell Media Market Key Segments: